Kidney disease market forecast reaching $159.57 billion by 2030 at 6.9% CAGR

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

By 2030, What Market Size Is The Kidney Disease Market Expected To Reach Based On Its 2026 Value?

The kidney disease market has experienced strong expansion in recent years. It is projected to increase from $114.39 billion in 2025 to $121.98 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.6%. The historical growth can be attributed to the rising prevalence of chronic kidney disease, an increasing incidence of diabetes and hypertension, the established utilization of dialysis and medication therapies, an expansion in hospital-based renal care, and the broadening availability of diagnostic testing.

The kidney disease market is poised for robust expansion in the upcoming years, with its size expected to reach $159.58 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.9%. This projected growth is driven by an aging global population facing higher renal risk, the increasing uptake of home-based dialysis, rising investment in kidney disease research, a heightened focus on early screening programs, and expanding access to renal care in emerging markets. Key trends influencing the forecast period include an increased emphasis on early detection and disease management, the growing adoption of dialysis and renal replacement therapies, an increasing demand for personalized kidney disease treatment, the expansion of multidisciplinary care models for renal patients, and improved patient awareness coupled with preventive care initiatives.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11938&type=smp

What Leading Drivers Are Supporting The Kidney Disease Market Expansion?

The rising occurrence of kidney diseases is anticipated to propel the expansion of the kidney disease market in the future. Kidney diseases refer to a range of conditions that impair the function and structure of the kidneys. Medications for kidney disorders are utilized to lower patients’ blood pressure and reduce protein loss, which helps slow the advancement of kidney damage, manage symptoms, and prevent complications. For instance, in June 2023, Kidney Research UK, a UK-based charitable organization dedicated to research and advocacy for kidney diseases, reported that an estimated 7.19 million people in the UK were affected by chronic kidney disease in 2023, representing over 10% of the UK population, with projections showing an increase to 7.61 million people by 2033. Therefore, the increasing incidence of kidney diseases is a primary driver for the growth of the kidney disease market.

How Is The Kidney Disease Market Broken Down By Segment Categories?

The kidney disease market covered in this report is segmented –

1) By Treatment: Medication, Dialysis, Surgery, Other Treatments

2) By Indication: Acute Kidney Injury, Chronic Kidney Disease, End-Stage Renal Disease, Other Indications

3) By Route Of Administration: Oral, Parenteral

4) By End-User: Hospitals, Diagnostic Laboratories, Other End-Users

Subsegments:

1) By Medication: Antihypertensives, Erythropoiesis-Stimulating Agents (ESAs), Phosphate Binders, Vitamin D Analogs, Immunosuppressants

2) By Dialysis: Hemodialysis, Peritoneal Dialysis

3) By Surgery: Kidney Transplant, Nephrectomy, Renal Artery Bypass, Ureteral Surgery

4) By Other Treatments: Lifestyle And Dietary Modifications, Renal Replacement Therapy, Palliative Care

What Emerging Trends Are Seen In The Kidney Disease Market?

Leading firms within the kidney disease market are prioritizing the integration of advanced technological innovations, specifically compact, cartridge-based hemodialysis systems, with the goal of improving treatment adaptability, patient user-friendliness, and operational effectiveness. These compact, cartridge-based hemodialysis units are portable dialysis devices that employ disposable dialysate cartridges rather than traditional bagged fluids. This design allows for automated dialysate preparation, simplified setup, and greater suitability for home-based therapy. For instance, in November 2024, Quanta Dialysis Technologies, a UK-based dialysis technology company, obtained FDA clearance for its Quanta Dialysis System, which is a cartridge-based hemodialysis system. This system is engineered to facilitate home hemodialysis and flexible care-setting deployment, characterized by a compact footprint, on-demand dialysate generation, and an intuitive touchscreen interface. The Quanta Dialysis System enhances patient autonomy, the simplicity of treatment delivery, and operational efficiency across various dialysis settings.

Which Players Are Present In The Kidney Disease Market Space?

Major companies operating in the kidney disease market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Novartis AG, AstraZeneca plc, Sanofi S.A., Bristol-Myers Squibb Company, AbbVie Inc., Bayer AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim International GmbH, Astellas Pharma Inc., Otsuka Pharmaceutical Co. Ltd., Mitsubishi Tanabe Pharma Corporation, Kyowa Kirin Co. Ltd., Vertex Pharmaceuticals Inc., Gilead Sciences Inc., Teva Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Limited, Lupin Limited, Aurobindo Pharma Limited

Get The Full Kidney Disease Market Report:

https://www.thebusinessresearchcompany.com/report/kidney-disease-global-market-report

Which Region Is The Largest In The Kidney Disease Market?

North America was the largest region in the kidney disease market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the kidney disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Kidney Disease Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/kidney-disease-global-market-report

Browse Through More Reports Similar to the Global Kidney Disease Market 2026, By The Business Research Company

Chronic Kidney Disease Market Report 2026

https://www.thebusinessresearchcompany.com/report/chronic-kidney-disease-global-market-report

Diabetic Kidney Disease Market Report

https://www.thebusinessresearchcompany.com/report/diabetic-kidney-disease-global-market-report

Rare Kidney Diseases Market Report

https://www.thebusinessresearchcompany.com/report/rare-kidney-diseases-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795